WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells

Inhibitors of cytochrome P450 (CYP) 1B1

(2017) Raphaël Dutour et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease

(2017) Ercole L. Cavalieri et al.   INTERNATIONAL JOURNAL OF CANCER

Potential role of CYP1B1 in the development and treatment of metabolic diseases

(2017) Fei Li et al.   PHARMACOLOGY & THERAPEUTICS

Lipid Metabolism Impairment in Human Gliomas: Expression of Peroxisomal Proteins in Human Gliomas at Different Grades of Malignancy

(2017) E. Benedetti et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Cytochrome P450 1B1: An unexpected modulator of liver fatty acid homeostasis

(2015) Michele Campaigne Larsen et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy

(2015) Heather L. Blackburn et al.   CANCER CAUSES & CONTROL

International Variation in Female Breast Cancer Incidence and Mortality Rates

(2015) C. E. DeSantis et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effects of Diisodecyl Phthalate on PPAR:RXR-Dependent Gene Expression Pathways in Sea Bream Hepatocytes

(2015) Paolo Cocci et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression

(2015) Jiahua Cui et al.   JOURNAL OF MEDICINAL CHEMISTRY

Hypoxia-inducible Lipid Droplet-associated (HILPDA) Is a Novel Peroxisome Proliferator-activated Receptor (PPAR) Target Involved in Hepatic Triglyceride Secretion

(2014) Frits Mattijssen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Leptin induces CYP1B1 expression in MCF-7 cells through ligand-independent activation of the ERα pathway

(2014) Tilak Khanal et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Integrated physiology and systems biology of PPARα

(2014) Sander Kersten   Molecular Metabolism

PPAR  and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia

(2013) S. Tung et al.   BLOOD

Inhibition of PPARα Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells

(2013) Omran Abu Aboud et al.   PLoS One

Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells

(2012) A Papi et al.   CELL DEATH AND DIFFERENTIATION

Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells

(2011) G. Laurenti et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

WY-14 643, a Selective PPARα Agonist, Induces Proinflammatory and Proangiogenic Responses in Human Ocular Cells

(2010) Jin-Zhong Zhang et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Prostaglandin E2 Induces CYP1B1 Expression via Ligand-Independent Activation of the ERα Pathway in Human Breast Cancer Cells

(2010) Eun H. Han et al.   TOXICOLOGICAL SCIENCES

Minireview: Nuclear Receptors and Breast Cancer

(2008) Suzanne D. Conzen   MOLECULAR ENDOCRINOLOGY